Soros Fund Management - SOLENO THERAPEUTICS INC ownership

SOLENO THERAPEUTICS INC's ticker is and the CUSIP is 834203309. A total of 115 filers reported holding SOLENO THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is 12.01 and the average weighting 0.7%.

Quarter-by-quarter ownership
Soros Fund Management ownership history of SOLENO THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$4,488,000
+4.9%
110,000
+10.0%
0.08%
+14.1%
Q1 2024$4,280,000100,0000.07%
Other shareholders
SOLENO THERAPEUTICS INC shareholders Q2 2024
NameSharesValueWeighting ↓
Vivo Capital, LLC 8,418,093$338,828,24327.74%
Ally Bridge Group (NY) LLC 309,950$12,475,4887.43%
Nantahala Capital Management 5,712,702$229,936,2566.88%
Vestal Point Capital, LP 1,300,000$52,325,0005.54%
Carlyle Group Inc. 2,857,804$115,038,7495.53%
Altium Capital Management LP 104,909$4,222,5872.87%
Perceptive Advisors 3,074,542$123,750,3152.76%
COMMODORE CAPITAL LP 700,000$28,175,0002.46%
Ikarian Capital, LLC 590,243$23,757,2812.22%
Ghost Tree Capital, LLC 112,385$4,523,4961.48%
View complete list of SOLENO THERAPEUTICS INC shareholders